-

$undefined

N/A

(N/A)

Climb Bio :CLYM

Location: | Industry: | Sector:


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-94.47M

Cash

193.4M

Avg Qtr Burn

-2.747M

Short % of Float

14.20%

Insider Ownership

10.18%

Institutional Own.

86.56%

Qtr Updated

09/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Budoprutug Details
Kidney disease, Primary Membranous Nephropathy

Phase 1b

Update

Failed

Discontinued

ETX-155 Details
Major depressive disorder, Perimenopausal Depression

Failed

Discontinued

ETX-810 Details
Chronic pain, Sciatica , Pain, Diabetes

Failed

Discontinued

Failed

Discontinued

ETX-810 Details
Chronic pain, Pain, Sciatica

Failed

Discontinued